CharonY Posted September 9, 2010 Share Posted September 9, 2010 An interesting paper about how pharma companies sneak marketing aspects into reviews and commentaries. Normally the FDA regulates what can be said about a drug in marketing. However in this report at least one company has been shown to circumvent that by ghostwriting articles that are designed to market their products. Needless to say this is an extremely unethical on so many levels (including also unethical treatment of authorship). Link Link to comment Share on other sites More sharing options...
Recommended Posts